retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) PART 7 | Triple Agonists

19, the FDA confirmed an earlier decision to remove tirzepatide from its drug shortage list

A diet heavy in refined carbohydrates and ultra-processed foods produces greater insulin spikes, more inflammation, worse gut microbiome diversity, and less favorable body composition changes compared to one centered on whole foods with adequate protein, healthy fats, and fiber

i tng s dng Ngi mun c ln da trng sng, u mu

Adherence to the EAT-lancet diet and incident depression and anxiety

At its core is a dental-grade carbamide peroxide formula enriched with Amorphous Calcium Phosphate (ACP), a remineralizing compound used by dental professionals to strengthen enamel during the whitening process

Semaglutide, a glucagon-like peptiede-1 (GLP-1) receptor agonist, was approved by the Food and Drug Administration (FDA) to treat diabetes in 2017 and for weight loss in 2021 [3]